2437.2000 -21.80 (-0.89%)
NSE Sep 04, 2026 15:31 PM
Volume: 412.7K
 

2437.20
-0.89%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 16.8% / 86.1% / 111.8% for the period of FY26-FY28.
Glenmark Pharmaceuti.. has an average target of 2434.50 from 4 brokers.
More from Glenmark Pharmace…
All earning calls
Investor presentations from Glenmark Pharmace…
All investor presentations